FTC sues main pharmacy benefit managers above insulin selling prices The company brought action versus Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the listing price of existence-preserving insulin prescription drugs. Investment decision in digital wellbeing companies arrived at years-very low ranges prev... https://aya-healthcare-address41753.activosblog.com/29942334/considerations-to-know-about-healthcare-news